Point72 Asset Management
ACIU icon

Point72 Asset Management’s AC Immune ACIU Stock Holding History

Point72 Asset Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-384,845
Closed -$1.2M – 3713
2025
Q4 		$1.21M Buy
+384,845
New +$1.21M ﹤0.01% 2768
2021
Q4 		– Sell
-228,000
Closed -$1.53M – 1063
2021
Q3 		$1.53M Sell
228,000
-148,600
-39% -$1.06M 0.01% 810
2021
Q2 		$2.99M Buy
+376,600
New +$2.6M 0.01% 689
2016
Q4 		– Sell
-10,000
Closed -$165K – 673
2016
Q3 		$165K Buy
+10,000
New +$173K ﹤0.01% 682

Other funds holding ACIU

Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Point72 Asset Management's ACIU Position: Q1 2026 in Review

Point72 Asset Management sold out of AC Immune (ACIU) in Q1 2026, closing a stake of 384,845 shares — an estimated $1.2M sold.

Point72 Asset Management first reported a position in ACIU in Q3 2016 and held it in 4 quarters. The position peaked at $2.99M in Q2 2021. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • Point72 Asset Management reported no remaining AC Immune position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 384,845 AC Immune shares in Q1 2026, an estimated $1.2M.
  • Point72 Asset Management first reported a position in AC Immune in Q3 2016 and held it in 4 quarters.
  • Point72 Asset Management's AC Immune position peaked at $2.99M in Q2 2021.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.